| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00000005269 |
| 007 |
he bmb024baca |
| 008 |
990805s1999 dcu bb f000 0 eng d |
| 005 |
20230331144151.3 |
| 035 |
|
|
|a (OCoLC)ocm42019474
|
| 035 |
|
|
|9 AJJ1771AM
|
| 035 |
|
|
|a in00000005269
|
| 037 |
|
|
|a 162093
|b GAO (202) 512-6000 (Voice); (202) 512-6061 (Fax)
|f paper copy
|
| 040 |
|
|
|a SEN
|c SEN
|d GPO
|d DLC
|d MvI
|d UtOrBLW
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a UMIC
|
| 049 |
|
|
|a WWW
|
| 074 |
|
|
|a 0546-D-01 (MF)
|
| 074 |
|
|
|a 0546-D-01 (online)
|
| 086 |
0 |
|
|a GA 1.5/2:T-NSIAD-99-148
|
| 100 |
1 |
|
|a Chan, Kwai-Cheung.
|
| 245 |
1 |
0 |
|a Medical readiness :
|b safety and efficacy of the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives /
|c United States General Accounting Office.
|
| 246 |
3 |
0 |
|a Safety and efficacy of the anthrax vaccine
|
| 264 |
|
1 |
|a Washington, D.C. (P.O. Box 37050, Washington, D.C. 20013) :
|b The Office,
|c [1999]
|
| 300 |
|
|
|a 7 pages ;
|c 28 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a microform
|b h
|2 rdamedia
|
| 338 |
|
|
|a microfiche
|b he
|2 rdacarrier
|
| 490 |
1 |
|
|a Testimony ;
|v GAO/T-NSIAD-99-148
|
| 500 |
|
|
|a Cover title.
|
| 500 |
|
|
|a Shipping list number: 99-0700-M.
|
| 500 |
|
|
|a "For release ... April 29, 1999."
|
| 500 |
|
|
|a "April 29, 1999."
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 533 |
|
|
|a Microfiche.
|b [Washington, D.C.] :
|c Supt. of Docs., U.S. G.P.O.,
|d [1999]
|e 1 microfiche : negative.
|7 s1999 dcun b
|
| 530 |
|
|
|a Also available via Internet from the GPO Access web site. Address as of 03/04/02: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:ns99148t.pdf; current access is available via PURL.
|
| 500 |
|
|
|a Microform.
|
| 650 |
|
0 |
|a Anthrax
|x Vaccination
|z United States.
|
| 650 |
|
0 |
|a Anthrax
|x Effectiveness
|z United States.
|
| 610 |
1 |
0 |
|a United States.
|b Food and Drug Administration
|v Rules and practice.
|
| 776 |
1 |
|
|c Original
|w (OCoLC)41523597
|
| 710 |
1 |
|
|a United States.
|b General Accounting Office.
|
| 830 |
|
0 |
|a Testimony ;
|v GAO/T-NSIAD-99-148.
|
| 856 |
4 |
1 |
|u https://purl.fdlp.gov/GPO/LPS17888
|z Adobe Acrobat Reader required
|t 0
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|i 94692280-e82c-3953-a490-3f979c2f65c2
|s 9a120b10-ac42-3ced-8763-0cbe97619df2
|t 0
|
| 952 |
f |
f |
|p normal
|a Texas A&M University
|b College Station
|c Sterling C. Evans Library
|d Evans: US Documents Microfiche (3rd floor)
|t 0
|e GA 1.5/2:T-NSIAD-99-148
|h Superintendent of Documents classification
|i microform -- microfiche
|m A14824501229
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e GA 1.5/2:T-NSIAD-99-148
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a GA 1.5/2:T-NSIAD-99-148
|t 0
|l Available Online
|
| 998 |
f |
f |
|a GA 1.5/2:T-NSIAD-99-148
|t 0
|l Evans: US Documents Microfiche (3rd floor)
|